Challenges in diagnosing hypersensitivity pneumonitis addres
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
More than 30 years after the last guidance on the clinical evaluation of hypersensitivity pneumonitis (HP), the American Thoracic Society - in collaboration with the Asociación Latinoamericana de Tórax or ALAT and the Japanese Respiratory Society- has developed new guidelines for clinicians. The guidelines are available online ahead of print in the American Journal of Respiratory and Critical Care Medicine.

Hypersensitivity pneumonitis manifests as interstitial lung disease. It is difficult to diagnose and until now, there has been little consensus in terms of disease definition, diagnostic criteria and diagnostic approach.

The guideline committee categorized HP into two clinical phenotypes, namely nonfibrotic and fibrotic HP, and made recommendations for reach. Their priority was to help clinicians make a confident and accurate diagnosis of HP.

The panel's recommendations were formulated using the Grading of Recommendations, Assessment, Development, and Evaluation approach (GRADE).

About the society:
Founded in 1905, the American Thoracic Society is the world's leading medical association dedicated to advancing pulmonary, critical care and sleep medicine. The ATS publishes four journals, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology, the Annals of the American Thoracic Society and ATS Scholar.

Note: This list is a brief compilation of some of the key recommendations included in the Guideline and is not exhaustive and does not constitute medical advice. Kindly refer to the original document attached below.

Source: https://www.atsjournals.org/doi/full/10.1164/rccm.202005-2032ST
S S and 7 others like this1 share
Like
Comment
Share